Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo
- PMID: 9166937
- PMCID: PMC2223492
- DOI: 10.1038/bjc.1997.249
Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo
Abstract
The gastrointestinal tract, with its rapid cell replacement, is sensitive to cytotoxic damage and can be a site of dose-limiting toxicity in cancer therapy. Here, we have investigated the use of one growth modulator to manipulate the cell cycle status of gastrointestinal stem cells before cytotoxic exposure to minimize damage to this normal tissue. Transforming growth factor beta-3 (TGF-beta3), a known inhibitor of cell cycle progression through G1, was used to alter intestinal crypt stem cell sensitivity before 12-16 Gy of gamma irradiation, which was used as a model cytotoxic agent. Using a crypt microcolony assay as a measure of functional competence of gastrointestinal stem cells, it was shown that the administration of TGF-beta3 over a 24-h period before irradiation increased the number of surviving crypts by four- to six-fold. To test whether changes in crypt survival are reflected in the well-being of the animal, survival time analyses were performed. After 14.5 Gy of radiation, only 35% of the animals survived within a period of about 12 days, while prior treatment with TGF-beta3 provided significant protection against this early gastrointestinal animal death, with 95% of the treated animals surviving for greater than 30 days.
Similar articles
-
Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling.Int J Cancer. 2000 Apr 1;86(1):53-9. doi: 10.1002/(sici)1097-0215(20000401)86:1<53::aid-ijc8>3.0.co;2-z. Int J Cancer. 2000. PMID: 10728594
-
Interleukin-11 protects the clonogenic stem cells in murine small-intestinal crypts from impairment of their reproductive capacity by radiation.Int J Cancer. 1995 Jul 28;62(3):356-61. doi: 10.1002/ijc.2910620321. Int J Cancer. 1995. PMID: 7628879
-
Teduglutide ([Gly2]GLP-2) protects small intestinal stem cells from radiation damage.Cell Prolif. 2004 Dec;37(6):385-400. doi: 10.1111/j.1365-2184.2004.00320.x. Cell Prolif. 2004. PMID: 15548172 Free PMC article.
-
Protection against mucosal injury by growth factors and cytokines.J Natl Cancer Inst Monogr. 2001;(29):16-20. doi: 10.1093/oxfordjournals.jncimonographs.a003433. J Natl Cancer Inst Monogr. 2001. PMID: 11694560 Review.
-
Ageing of murine small intestinal stem cells.Novartis Found Symp. 2001;235:66-79; discussion 79-84, 101-4. doi: 10.1002/0470868694.ch7. Novartis Found Symp. 2001. PMID: 11280034 Review.
Cited by
-
Vimentin protein is a factor for decreasing breast cancer cell proliferation co-culture with human bone marrow-derived mesenchymal stem cells pre-treated with thiazolidinedione solutions.Mol Biol Rep. 2024 Feb 21;51(1):317. doi: 10.1007/s11033-024-09269-z. Mol Biol Rep. 2024. PMID: 38381204
-
TGF-B3 Dependent Modification of Radiosensitivity in Reporter Cells Exposed to Serum From Whole-Body Low Dose-Rate Irradiated Mice.Dose Response. 2015 May 4;13(1):dose-response.14-015.Edin. doi: 10.2203/dose-response.14-015.Edin. eCollection 2015 Jan-Mar. Dose Response. 2015. PMID: 26673923 Free PMC article.
-
Single cell lineage tracing reveals a role for TgfβR2 in intestinal stem cell dynamics and differentiation.Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12192-12197. doi: 10.1073/pnas.1611980113. Epub 2016 Oct 10. Proc Natl Acad Sci U S A. 2016. PMID: 27791005 Free PMC article.
-
Stem Cell Therapy Using Bone Marrow-Derived Muse Cells Repairs Radiation-Induced Intestinal Injury Through Their Intestine-Homing via Sphingosine Monophosphate-Sphingosine Monophosphate Receptor 2 Interaction.Adv Radiat Oncol. 2024 Jul 9;9(9):101565. doi: 10.1016/j.adro.2024.101565. eCollection 2024 Sep. Adv Radiat Oncol. 2024. PMID: 39188997 Free PMC article.
-
TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome.PLoS One. 2012;7(1):e29357. doi: 10.1371/journal.pone.0029357. Epub 2012 Jan 4. PLoS One. 2012. PMID: 22238604 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical